Tom Mikkelsen
President & CSO @ Ontario Brain Institute
Detroit, United States
Tom Mikkelsen is a grant investor at Ontario Brain Institute in Detroit focused on Health Care and Neuroscience. Tom Mikkelsen is the President and CSO of Ontario Brain Institute. He previously worked at Henry Ford Hospital as a CoDirector. Tom Mikkelsen attended the University of Calgary.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 90%
Last updated:
For AI agents: llms.txt
Industries Tom Mikkelsen invests in
Stages Tom Mikkelsen invests in
Countries Tom Mikkelsen invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 6 (60%)
- Neuroscience 4 (40%)
- Medical Device 4 (40%)
- Medical 3 (30%)
- Hospital 3 (30%)
Stage
- Grant 8 (80%)
- Seed 1 (10%)
- Venture - Series Unknown 1 (10%)
Country
- Canada 6 (60%)
- United States 2 (20%)
- France 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Grey Matter Neurosciences is a neurotechnology firm developing new medical devices and drug-device combinations to treat age-related brain illnesses like dementia. | $14M / Seed / Jan 23, 2025 | ||
| Panaxium is a bioelectronic medicine company that aims to fundamentally change the way neurological diseases are treated by leveraging the benefits of AI-enabled intronic devices. | Venture - Series Unknown / Apr 10, 2023 | ||
| Specializes in co-creating interactive media for children of all abilities for wellness, play, and learning. Our flagship product, a video game system called Bootle BlastTM, uses an innovative mixed reality technology to engage children and youth with neuromotor conditions in exercises that improve functional abilities. | $100K / Grant / May 12, 2022 | ||
| Cove Neurosciences are changing the way data is used to study the human brain. Cove Neurosciences is a brain data science's next generation. | $100K / Grant / May 12, 2022 | ||
| Raft Digital Therapeutics constructs a virtual platform for assistance to allow unattended at-home programming. give patients an affordable option that promotes long-term follow-through by making exercise enjoyable. To create goods with enduring appeal, a team assembles industry, technical, and business specialists. | $100K / Grant / May 12, 2022 | ||
| Ora Medical's rehabilitation technology helps children with mobility challenges. The Levity, our first device, is a smart pediatric gait trainer that supports a child with an innovative partial weight-bearing mechanism. This allows the child to interact with the world using their arms, unlocking tons of possibilities for enhanced independenceand freedom. The real-time data collected helps parents and clinicians track each child's journey. | $100K / Grant / May 12, 2022 | ||
| Novela Neurotech is medical technology startup with a research legacy in neuromodulation originating in the University of Waterloo in Canada. Novela has developed the Neureka™ smart technology platform to accelerate the discovery & development of new safer treatments for epilepsy, narcotic addiction, depression, Alzheimer's,Parkinson's diseases, and many other neurological disorders | $100K / Grant / May 12, 2022 | ||
| Prescription AR glasses for people afflicted by aged macular degeneration | $100K / Grant / May 12, 2022 | ||
| Our goal is to improve the lives of those who are suffering from stress and burnout | $100K / Grant / Feb 12, 2022 | ||
| PragmaClin is revolutionising neurological disease monitoring by utilising cutting-edge digital tools to manage movement disorder assessments from the comfort of one's own home. | Grant |
Co-Investors
About Ontario Brain Institute
The Ontario Brain Institute is a provincially‐funded, not‐for‐profit research centre seeking to maximize the impact of neuroscience and establish Ontario as a world leader in brain research, commercialization and care. Convergent partnerships are created between researchers, clinicians, industry, patients, and their advocates to foster discoveryand deliver innovative products and services that improve the lives of those living with brain disorders.Our Vision: Ontario as a world leader in brain research, commercialization and care.
Ontario Brain Institute Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Tom Mikkelsen
President & CSO
|
|||
Anna Han
Senior Lead, Industry Relations Portfolio Management
|
|||
Bryce Pickard
SVP and COO
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Tom Mikkelsen invest in?
Tom Mikkelsen invests primarily in Health Care, Neuroscience and Medical Device startups, most often at Grant and Seed stage. Most of the 10 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tom Mikkelsen?
Public channels for Tom Mikkelsen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tom Mikkelsen last invest?
The most recent investment recorded for Tom Mikkelsen closed in Jan 2025. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
